Ami Schattner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ami Schattner has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Ina Dubin
Department of Medicine, Laniado University Hospital, Sanz Medical Centre , Divrey-Hayim 16, Netanya 4244916
72 shared publicationsYair Glick
Faculty of Medicine, Hebrew University and Hadassah Medical School (AS), Jerusalem, Israel
38 shared publicationsLivnat Uliel
Adelson School of Medicine, Ariel University, 40700 Ariel, Israel
21 shared publicationsMoshe Gelber
Department of Medicine, Laniado Hospital, Sanz Medical Center, Netanya, Israel
6 shared publicationsMeital Adi
Department of Imaging, Kaplan Medical Center, Rehovot and the Faculty of Medicine, Hebrew University and Hadassah Medical School, Jerusalem, Israel
5 shared publicationsTalya Finn
Adelson School of Medicine, Ariel University , Ariel, Israel
5 shared publications
Latest Publications
- 11 November 2026
- Published by Elsevier in The American Journal of Medicine
Patient-Centered Hospitalization to Improve Inpatient Safety
- 11 November 2026
- Published by Elsevier in The American Journal of Medicine
Patient-Centered Hospitalization to Improve Inpatient Safety
- Open Access
- 19 October 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
Loperamide overdose–associated euphoria and delirium
- 19 October 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
Open AccessLoperamide overdose–associated euphoria and delirium
- Open Access
- 16 October 2026
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 13 (11)
Scleroedema preceding monoclonal gammopathy by 30 years
Three decades after the diagnosis of scleroedema (Buschke’s disease), a benign chronic sclerotic skin condition of unknown pathogenesis without systemic involvement, a patient developed secondary gout and normocytic anaemia. Investigations revealed monoclonal gammopathy of undetermined significance, with 1.3 g/dl immunoglobulin G-lambda in the gamma region, a clinically important albeit rare scleroedema-related manifestation, with associated low complement component 4 levels and Coomb’s positivity, but no myeloma or amyloidosis.
- 16 October 2026
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 13 (11)
Open AccessScleroedema preceding monoclonal gammopathy by 30 years
Three decades after the diagnosis of scleroedema (Buschke’s disease), a benign chronic sclerotic skin condition of unknown pathogenesis without systemic involvement, a patient developed secondary gout and normocytic anaemia. Investigations revealed monoclonal gammopathy of undetermined significance, with 1.3 g/dl immunoglobulin G-lambda in the gamma region, a clinically important albeit rare scleroedema-related manifestation, with associated low complement component 4 levels and Coomb’s positivity, but no myeloma or amyloidosis.
- 16 October 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
The GP crisis dissected: an outsider’s view
- 16 October 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
The GP crisis dissected: an outsider’s view
- 6 October 2026
- Published by Springer Nature in Internal and Emergency Medicine
- p. 1-2
Not all diverticulosis are colonic – jejunal diverticulitis
- 6 October 2026
- Published by Springer Nature in Internal and Emergency Medicine
- p. 1-2
Not all diverticulosis are colonic – jejunal diverticulitis
- Open Access
- 2 October 2026
- Published by Elsevier in The American Journal of Medicine
Falls in the elderly: under-appreciated serious sequela. A narrative review
- 2 October 2026
- Published by Elsevier in The American Journal of Medicine
Open AccessFalls in the elderly: under-appreciated serious sequela. A narrative review
- Open Access
- 27 August 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
Lytic bone lesions in a patient diagnosed with breast cancer—sarcoidosis
- 27 August 2026
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
Open AccessLytic bone lesions in a patient diagnosed with breast cancer—sarcoidosis
- Open Access
- 2 August 2026
- Published by Elsevier in The American Journal of Medicine
Longitudinal changes in anemia during acute inflammatory disease
- 2 August 2026
- Published by Elsevier in The American Journal of Medicine
Open AccessLongitudinal changes in anemia during acute inflammatory disease
- Open Access
- 23 July 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (7)
Hepatocellular Carcinoma Presenting With Extensive Portal Vein Tumour Thrombus Without Evidence of Underlying Liver Cirrhosis or Steatosis: A Case Report
Aims/Background:Most cases of hepatocellular carcinoma (HCC) develop in the setting of chronic liver disease (CLD), usually with chronic inflammation, fibrosis, or cirrhosis. The case aims to highlight a rare presentation without evidence of prior CLD.Case Presentation:An older adult patient with no risk factors for CLD other than type 2 diabetes, overweight, and hypertension presented with high-gradient ascites, splenomegaly and hypersplenism due to portal hypertension. Results:Imaging identified an extensive tumour thrombus extending from the portal vein and hepatic veins to the inferior vena cava and right atrium—adjacent to a liver mass. Alpha-fetoprotein was extremely elevated. Ultrasound-guided core liver needle biopsy of the mass was diagnostic of HCC. Biosynthetic liver functions were preserved, liver imaging did not show cirrhosis or steatosis, and liver tissue adjacent to the tumour showed no CLD.Conclusion:HCC may rarely present with tumour thrombus-associated portal hypertension and ascites, and very rarely arise with no demonstrable background of liver pathology. Absence of demonstrable CLD does not rule out HCC and its complications.
- 23 July 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (7)
Open AccessHepatocellular Carcinoma Presenting With Extensive Portal Vein Tumour Thrombus Without Evidence of Underlying Liver Cirrhosis or Steatosis: A Case Report
Aims/Background:Most cases of hepatocellular carcinoma (HCC) develop in the setting of chronic liver disease (CLD), usually with chronic inflammation, fibrosis, or cirrhosis. The case aims to highlight a rare presentation without evidence of prior CLD.Case Presentation:An older adult patient with no risk factors for CLD other than type 2 diabetes, overweight, and hypertension presented with high-gradient ascites, splenomegaly and hypersplenism due to portal hypertension. Results:Imaging identified an extensive tumour thrombus extending from the portal vein and hepatic veins to the inferior vena cava and right atrium—adjacent to a liver mass. Alpha-fetoprotein was extremely elevated. Ultrasound-guided core liver needle biopsy of the mass was diagnostic of HCC. Biosynthetic liver functions were preserved, liver imaging did not show cirrhosis or steatosis, and liver tissue adjacent to the tumour showed no CLD.Conclusion:HCC may rarely present with tumour thrombus-associated portal hypertension and ascites, and very rarely arise with no demonstrable background of liver pathology. Absence of demonstrable CLD does not rule out HCC and its complications.
- 12 July 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (7) , e70770
Remission Induction Therapy in Rheumatic Diseases: Pre‐Emptive Treatment of CMV Reactivation?
- 12 July 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (7) , e70770
Remission Induction Therapy in Rheumatic Diseases: Pre‐Emptive Treatment of CMV Reactivation?